시장보고서
상품코드
1384652

세계의 기관지경 시장 규모, 점유율, 산업 동향 분석 리포트 : 유형별, 용도별, 최종 용도별, 지역별 전망과 예측(2023-2030년)

Global Bronchoscopes Market Size, Share & Industry Trends Analysis Report By Type (Flexible (Video, Fiberoptic, Hybrid), and Rigid), By Usage, By End Use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 346 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

기관지경 시장 규모는 예측 기간 중 CAGR 6.9%로 성장하며, 2030년에는 44억 달러에 달할 것으로 예측됩니다. 2022년 시장 규모는 130만 8,100대, 성장률은 9.6%입니다.(2019-2022년)

KBV Cardinal matrix에 제시된 분석에 따르면 Johnson & Johnson이 이 시장의 선구자입니다. Medtronic PLC, Fujifilm Holdings Corporation, Olympus Corporation 등의 기업은 시장의 주요 이노베이터입니다. 2022년 7월, Medtronic PLC는 기관지경 수술에 사용되는 시스템, ILLUMISITE의 발매를 발표했습니다. 이 시스템은 저침습설비, 조직 이상에 대한 더 나은 가시성, 병변에 대한 액세스의 확대 등 몇개의 이점을 제공합니다.

COVID-19의 영향 분석

COVID-19로 인해 가장 큰 영향을 받은 시스템은 호흡기로 기관지경 및 기타 호흡기 진단 툴에 대한 수요가 급증했습니다. 병원과 의료 시설은 COVID-19 환자, 특히 중증 호흡기 증상이 있는 환자의 진단과 치료를 위해 기관지경을 필요로 했습니다. 많은 의료시설은 자원을 재분배하고 COVID-19 관련 치료와 장비에 우선순위를 두어야 했습니다. COVID-19는 새로운 의료기기 및 기술 개발 등 의료 분야의 연구개발을 가속화했습니다. 그 결과 기관지경 디자인과 기능의 혁신이 이루어졌습니다. 감염 예방은 의료 현장에서 최우선 과제로 떠오르고 있습니다. 제조업체와 의료 서비스 프로바이더는 교차 오염의 위험을 줄이기 위해 기관지경의 멸균 및 세척 프로토콜을 강화했습니다. 따라서 COVID-19 팬데믹은 시장에 중간 정도의 영향을 미쳤습니다.

시장 성장 요인

호흡기 질환 증가

폐암, 만성폐쇄성폐질환(COPD), 천식, 폐렴 등 호흡기 질환의 발병률 증가로 진단 및 치료를 위한 기관지경 검사에 대한 수요가 증가하고 있습니다. 폐암은 세계에서 암 관련 사망의 주요 원인 중 하나입니다. 진단, 병기 결정 및 치료 계획을 위해 기관지경 수술이 필요한 경우가 많습니다. 기관지경 검사를 통한 조기 발견과 정확한 진단은 생존율을 높이기 위해 매우 중요하며, COPD는 만성 기관지염과 폐기종을 포함하는 질환입니다. 기관지경 검사는 기도의 염증을 평가하고, 진단을 위한 조직 샘플을 채취하고, 증상을 관리하고 폐 기능을 개선하기 위한 치료적 개입을 수행합니다. 호흡기 질환의 유병률 증가는 시장 성장의 중요한 촉진제입니다.

원격의료 및 원격진료 도입 확대

원격의료 및 원격의료 서비스의 성장으로 기관지경 치료의 범위가 확대되고 있습니다. 비디오 기관지경을 통해 의료 전문가는 원격 진료와 전문의와의 협진을 할 수 있습니다. 원격의료는 원격지나 의료 서비스가 부족한 지역의 환자들이 먼 거리를 이동하지 않고도 기관지 내시경 검사 및 후속 치료를 포함한 의료 서비스를 이용할 수 있게 해줍니다. 원격의료는 의료진이 환자와 원격으로 진료할 수 있게 해줍니다. 기관지 내시경 소견, 이미지, 영상을 전문가와 공유하고 평가와 조언을 받을 수 있으므로 지역적 위치에 관계없이 전문가의 의견을 들을 수 있습니다. 원격의료와 원격의료 서비스의 성장은 시장에 큰 영향을 미치고 있습니다.

시장 성장 억제요인

높은 감염 위험

기관지 내시경 수술은 감염의 위험을 수반합니다. 의료 관련 감염을 예방하기 위해서는 기관지경의 적절한 세척, 소독 및 멸균을 보장하는 것이 매우 중요합니다. 기관지경은 여러 채널과 컴포넌트가 있는 복잡한 의료기기이기 때문에 완전한 세척이 어렵습니다. 미생물 생물막을 포함한 오염 물질은 틈새와 채널에 숨어있을 수 있으며, 감염 전파의 위험을 증가시킬 수 있습니다. 기관지경 세척 및 재처리에서 인위적인 실수는 심각한 우려 사항입니다. 수작업으로 세척, 소독, 멸균을 잘못하면 감염 인자를 보유한 오염 물질이 남을 수 있습니다. 그 결과, 감염 클러스터 및 발병의 발견이 지연될 수 있습니다. 기관지경과 관련된 감염 전파의 위험은 의료 산업과 시장에서 중요한 도전이 되고 있습니다.

유형별 전망

기관지 내시경 시장은 유형별로 경질형과 연질형으로 분류됩니다. 광섬유 부문은 2022년 시장에서 큰 매출 점유율을 차지했습니다. 연성 기관지 내시경은 직경이 작고 침습성이 낮기 때문에 시술 중 환자의 불편함과 불안을 줄일 수 있습니다. 연성 기관지경은 다재다능하여 다양한 진단 및 치료 절차에 사용할 수 있습니다. 기관지 및 말초기도를 포함한 전체 기도를 관찰하는 데 적합합니다. 연성 기관지 내시경은 유연성이 뛰어나 기도 내에서의 조작과 탐색이 용이합니다. 연성 기관지 내시경의 장점은 환자 친화적 인 디자인, 다목적성, 고급 이미지 처리 능력, 다양한 진단 및 치료 용도에 대한 적합성 등입니다. 기관지경은 호흡기 의료의 표준 툴이 되었으며 폐 및 호흡기 질환의 진단 및 치료에 중요한 역할을 하고 있습니다.

유연성형 전망

유연한 유형에서 시장은 비디오, 광섬유 및 하이브리드로 나뉘며, 2022년 시장에서 광섬유 부문이 큰 매출 점유율을 차지했습니다. 광섬유 기관지경은 일반적으로 진단 목적으로 사용됩니다. 의료 서비스 프로바이더가 기관지 나무를 검사하고 종양, 감염, 이물질, 염증과 같은 이상을 감지 할 수 있습니다. 광섬유 번들이 제공하는 광학 선명도로 인해 정확한 시각화가 가능합니다. 광섬유 기관지경은 기도 검사, 기도 개방성 평가, 폐색 및 병변을 식별하는 데 사용됩니다. 기침, 객혈, 천명음 등 호흡기 증상이 있는 환자를 평가할 때 유용한 툴입니다. 광섬유 기관지경은 음식물 찌꺼기나 흡입물과 같은 이물질을 찾아 기도에서 제거하는 데 사용됩니다. 기관지경의 유연성과 조작성은 이러한 시술의 정확성을 돕습니다.

용도별 전망

용도에 따라 시장은 재사용 및 일회용 부문으로 분류되며, 2022년 시장에서는 일회용 부문이 상당한 매출 점유율을 차지할 것으로 예상됩니다. 일회용 기관지경은 통제된 조건에서 제조되기 때문에 각 스코프가 최적의 성능을 발휘할 수 있도록 보장합니다. 이러한 일관성은 이미지 품질과 기능성이 필수적인 중요한 시술에서 특히 중요합니다. 의료 서비스 프로바이더는 일회용 기관지 내시경을 설치, 교정 및 멸균이 필요없고 즉시 사용할 수 있으므로 편리하다고 생각합니다. 이것은 특히 응급 상황에서 유리합니다. 일회용 기관지경은 재처리 시설에 대한 접근이 제한적이거나 현실적이지 않은 외딴 지역이나 현장에서 사용하기에 적합합니다.

최종 용도 전망

최종 용도별로 시장은 병원과 외래 시설로 구분되며, 2022년에는 병원 부문이 시장에서 가장 큰 매출 점유율을 기록할 것으로 예상됩니다. 병원은 진단 목적으로 기관지경을 사용합니다. 기관지경을 환자의 기도에 삽입하여 기관, 기관지 및 기관지를 시각화합니다. 이를 통해 종양, 감염, 염증, 출혈 등의 이상을 확인할 수 있습니다. 기관지경으로 기도에서 조직 샘플을 채취해 병리과로 보내 분석할 수도 있습니다. 병원에서는 기관지경을 치료 목적으로 활용하고 있습니다. 약물 투여, 천식 관리를 위한 기관지 열 성형술, 객혈(피를 토하는 것), 협착(기도가 좁아지는 것) 등의 질환을 치료하는 데 사용됩니다.

지역별 전망

지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석되며, 2022년에는 북미가 가장 높은 매출 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 이 지역의 첨단화된 의료 인프라는 기관지경을 포함한 최신 의료 기술 및 의료 장비의 도입을 가능하게 합니다. 양질의 의료 시설과 숙련된 인력이 시장 성장에 기여하고 있습니다. 북미는 의료 기술 혁신의 중심지입니다. 이 지역의 제조업체들은 고화질 영상, 향상된 조작성, 디지털 시스템과의 통합을 실현한 디지털 비디오 기관지경과 같은 첨단 기관지경 기술을 지속적으로 개발 및 도입하고 있습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장의 개요

  • 주요 하이라이트

제3장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 촉진요인
    • 시장 억제요인

제4장 경쟁 분석 - 세계

  • KBV Cardinal Matrix
  • 최근 업계 전체의 전략적 개발
    • 파트너십, 협업 및 계약
    • 제품 발매와 제품의 확대
    • 인수합병
    • 시험과 승인
  • 주요 성공 전략
    • 주요 전략
    • 주요 전략적 동향
  • Porter's Five Forces 분석

제5장 세계의 기관지경 시장 : 유형별

  • 세계의 플렉서블 시장 : 지역별
  • 세계의 기관지경 시장 : 플렉서블 유형별
    • 세계의 비디오 시장 : 지역별
    • 세계의 광섬유 시장 : 지역별
    • 세계의 하이브리드 시장 : 지역별
  • 세계의 리지드 시장 : 지역별

제6장 세계의 기관지경 시장 : 용도별

  • 세계의 재사용 가능 시장 : 지역별
  • 세계의 일회용 시장 : 지역별

제7장 세계의 기관지경 시장 : 최종 용도별

  • 세계의 병원 시장 : 지역별
  • 세계의 외래 시설 시장 : 지역별

제8장 세계의 기관지경 시장 : 지역별

  • 북미 시장
  • 유럽 시장
  • 아시아태평양 시장
  • 라틴아메리카·중동 및 아프리카 시장

제9장 기업 개요

  • Olympus Corporation
  • Ambu A/S
  • Karl Storz SE & Co KG
  • Fujifilm Holdings Corporation
  • Boston Scientific Corporation
  • Cook Medical, Inc(Cook Group)
  • Medtronic PLC
  • Johnson & Johnson
  • Richard Wolf GmbH(The Richard and Annemarie Wolf Foundation)
  • Teleflex, Inc

제10장 시장의 성공 필수 조건

KSA 23.12.04

The Global Bronchoscopes Market size is expected to reach $4.4 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,308.1 thousand units, experiencing a growth of 9.6% (2019-2022).

Video bronchoscopes have high-resolution cameras and advanced imaging technologies, such as high-definition (HD) and 4K video capabilities. Hence, video segment would acquire approximately 1/2th share in the Flexible segment of the market by 2030. These technologies provide clear and detailed images of the respiratory tract, allowing healthcare professionals to visualize and assess the airway more effectively. Video bronchoscopes offer real-time visualization of the airway during procedures. This real-time feedback is crucial for diagnosing conditions, guiding interventions, and ensuring patient safety. Video bronchoscopes allow healthcare providers to document procedures by recording video and capturing images. This documentation can be used for patient records, education, and consultation with colleagues, contributing to improved patient care.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope. In November, 2022, Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter.

Based on the Analysis presented in the KBV Cardinal matrix; Johnson & Johnson is the forerunner in the Market. Companies such as Medtronic PLC, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in the Market. In July, 2022, Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.

COVID-19 Impact Analysis

The respiratory system was the system that COVID-19 most affected, which caused a spike in demand for bronchoscopes and other diagnostic tools for the respiratory system. Hospitals and healthcare facilities needed bronchoscopes to diagnose and treat COVID-19 patients, especially those with severe respiratory symptoms. Many healthcare facilities had to reallocate resources and prioritize COVID-19-related care and equipment. The pandemic accelerated research and development efforts in the healthcare sector, including developing new medical devices and technologies. This led to innovations in bronchoscope design and functionality. Infection control measures became a top priority in healthcare settings. Manufacturers and healthcare providers implemented enhanced sterilization and cleaning protocols for bronchoscopes to reduce the risk of cross-contamination. Therefore, COVID-19 pandemic had a moderate effect on the market.

Market Growth Factors

Rising prevalence of respiratory diseases

The increasing incidence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and pneumonia has driven the demand for bronchoscopic procedures for diagnosis and treatment. Lung cancer is one of the leading causes of cancer-related deaths globally. It often requires bronchoscopic procedures for diagnosis, staging, and treatment planning. Early detection and accurate diagnosis through bronchoscopy are critical for improving survival rates. COPD comprises conditions including chronic bronchitis and emphysema. It assess airway inflammation, collect tissue samples for diagnosis, and provide therapeutic interventions to manage symptoms and improve lung function. The rising prevalence of respiratory diseases is a significant driver of growth in the market.

Growing adoption of telemedicine and remote consultations

The growth of telemedicine and remote healthcare services has expanded the reach of bronchoscopic procedures. Video bronchoscopes enable healthcare professionals to conduct remote consultations and collaborate with specialists. Telemedicine authorizes patients in remote or underserved areas to access healthcare services, including bronchoscopic consultations and follow-up care, without traveling long distances to a healthcare facility. Telemedicine enables healthcare providers to conduct remote consultations with patients. Bronchoscopic findings, images, and videos can be shared with specialists for evaluation and recommendations, allowing expert input regardless of geographical location. The growth of telemedicine and remote healthcare services has significantly impacted the market.

Market Restraining Factors

Higher risk of infection transmission

Bronchoscopic procedures carry the risk of infection transmission. Ensuring proper cleaning, disinfection, and sterilization of bronchoscopes is crucial to prevent healthcare-associated infections. Bronchoscopes are intricate medical devices with multiple channels and components, which makes them challenging to clean thoroughly. Contaminants, including microbial biofilms, can hide in crevices and channels, increasing the risk of infection transmission. Human error during the cleaning and reprocessing of bronchoscopes is a significant concern. Manual cleaning, disinfection, or sterilization errors can leave behind contaminants that harbour infectious agents. This can result in delayed recognition of infection clusters or outbreaks. The risk of infection transmission associated with bronchoscopes presents a significant challenge in the healthcare industry and the market.

Type Outlook

Based on type, the market is classified into rigid and flexible. The fiberoptic segment garnered a significant revenue share in the market in 2022. Flexible bronchoscopes have a smaller diameter and are less invasive, which can reduce patient discomfort and anxiety during the procedure. Flexible bronchoscopes are highly versatile and can be used for various diagnostic and therapeutic procedures. They are suitable for visualizing the entire respiratory tract, including the bronchi and peripheral airways. Flexible bronchoscopes are easier to maneuver and navigate through the airways due to their flexibility. The advantages of flexible bronchoscopes include their patient-friendly design, versatility, advanced imaging capabilities, and suitability for various diagnostic and therapeutic applications. They have become a standard tool in respiratory medicine and play a significant role in diagnosing and treating lung and airway disorders.

Flexible Outlook

Under flexible type, the market is divided into video, fiberoptic, and hybrid. The fiberoptic segment garnered a significant revenue share in the market in 2022. Fiberoptic bronchoscopes are commonly used for diagnostic purposes. They allow healthcare providers to examine the bronchial tree and detect abnormalities like tumours, infections, foreign bodies, and inflammation. The optical clarity provided by fiberoptic bundles enables precise visualization. Fiberoptic bronchoscopes are used to inspect the airway, assess airway patency, and identify any obstructions or lesions. They are valuable tools for evaluating patients with respiratory symptoms, including cough, hemoptysis, and wheezing. Fiberoptic bronchoscopes are used to locate and remove foreign objects, such as food particles or inhaled objects, from the airway. Their flexibility and maneuverability aid in precision during these procedures.

Usage Outlook

By usage, the market is categorized into reusable and disposable. The disposable segment covered a considerable revenue share in the market in 2022. Disposable bronchoscopes are manufactured under controlled conditions, ensuring that each scope is optimal. This consistency can be especially important for critical procedures where image quality and functionality are essential. Healthcare providers find disposable bronchoscopes convenient because they can be used immediately without the need for setup, calibration, or sterilization. This can be particularly advantageous in emergencies. Disposable bronchoscopes are well-suited for use in remote or field settings where access to reprocessing facilities is limited or impractical.

End Use Outlook

On the basis of end-use, the market is segmented into hospitals and outpatient facilities. In 2022, the hospitals segment registered the maximum revenue share in the market. Hospitals use bronchoscopes for diagnostic purposes. These procedures involve the insertion of the bronchoscope into the patient's airways to visualize the trachea, bronchi, and bronchioles. This helps identify abnormalities like tumours, infections, inflammation, and bleeding. It enables the collection of tissue samples from the airways, which are then sent to the pathology department for analysis. Hospitals utilize bronchoscopes for therapeutic purposes. They can be used to deliver medications, perform bronchial thermoplasty for asthma management, or treat conditions like hemoptysis (coughing up blood) or strictures (narrowing of airways).

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The region's advanced healthcare infrastructure enables the adoption of the latest medical technologies and devices, including bronchoscopes. High-quality healthcare facilities and a skilled workforce contribute to the market's growth. North America is a hub for medical technology innovation. Manufacturers in the region continually develop and introduce advanced bronchoscope technologies, such as digital video bronchoscopes with high-definition imaging, enhanced manoeuvrability, and integration with digital systems.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Olympus Corporation, Ambu A/S, Karl Storz SE & Co. KG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Johnson & Johnson, Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)

Recent Strategies Deployed in Bronchoscopes Market

Product Launches and Product Expansions:

Jan-2023: Fujifilm Holdings Corporation unveiled PB2020-M2, an ultrasonic probe system for enhanced examination. The probe has an outer diameter range of 1.4-1.9mm and is compatible with a 2mm working channel bronchoscope.

Nov-2022: Fujifilm Holdings Corporation introduced EB-710P, a slim video bronchoscope. The EB-710P comes with a compact CMOS sensor and a 4.1 mm tip diameter. Additionally, it has a teardrop-shaped dial which facilitates smooth handling during procedures.

Jul-2022: Medtronic PLC announced the launch of ILLUMISITE, a system used for bronchoscopic procedures. The system offers several benefits including minimally invasive facility, better visibility for tissue abnormality, expanded access for lesions, etc.

Apr-2021: Olympus Corporation announced the launch of H-SteriScope Single-Use Bronchoscopes, a series of five single-use endoscopes used for diagnostic and therapeutic procedures. The bronchoscopes feature an outer diameter range of 2.2 to 6.2 mm and working channels that span 1.2 to 3.2 mm. Additionally, the bronchopes have a rotary function for east positioning and Tip Angulation for easy target access.

Mergers & Acquisition:

Sep-2021: Boston Scientific Corporation took over the international surgical business of Lumenis, a medical device manufacturer based in Israel. The acquisition complements Boston Scientific's kidney stone management portfolio and expands its presence in Europe and Asia.

Jun-2021: Boston Scientific Corporation announced the acquisition of Farapulse Inc., a medical device manufacturing company. The acquisition complements and strengthens Boston Scientific's electrophysiology portfolio.

Partnerships, Collaborations & Agreements:

Apr-2023: Fujifilm Holdings Corporation partnered with Tata Memorial Center, an Indian cancer research institute, to establish a training facility in the Tata Memorial Center. The partnership comes in line with Fujifilm's aim to improve healthcare in the Indian market.

Trials and Approvals:

Jul-2022: Ambu A/S received approval from the US FDA for its Ambu aScopeTM 5 Broncho, a series of single-use sterile bronchoscopes.

Aug-2021: Boston Scientific Corporation announced the US FDA approval for its announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT Model B Single-Use Bronchoscope. The EXALT Model B Bronchoscope is used for a variety of bronchoscopy procedures including secretion management, percutaneous tracheostomy, airway intubation, etc.

Scope of the Study

Market Segments covered in the Report:

By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)

  • Flexible
    • Video
    • Fiberoptic
    • Hybrid
  • Rigid

By Usage (Volume, Thousand Units, USD Billion/Million, 2019-2030)

  • Reusable
  • Disposable

By End Use (Volume, Thousand Units, USD Billion/Million, 2019-2030)

  • Hospitals
  • Outpatient Facilities

By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Teleflex, Inc.
  • Olympus Corporation
  • Ambu A/S
  • Karl Storz SE & Co. KG
  • Fujifilm Holdings Corporation
  • Boston Scientific Corporation
  • Cook Medical, Inc. (Cook Group)
  • Medtronic PLC
  • Johnson & Johnson
  • Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Bronchoscopes Market, by Type
    • 1.4.2 Global Bronchoscopes Market, by Usage
    • 1.4.3 Global Bronchoscopes Market, by End Use
    • 1.4.4 Global Bronchoscopes Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials and Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Jul - 2023, Jan) Leading Players
  • 4.4 Porter Five Forces Analysis

Chapter 5. Global Bronchoscopes Market, By Type

  • 5.1 Global Flexible Market, By Region
  • 5.2 Global Bronchoscopes Market, By Flexible Type
    • 5.2.1 Global Video Market, By Region
    • 5.2.2 Global Fiberoptic Market, By Region
    • 5.2.3 Global Hybrid Market, By Region
  • 5.3 Global Rigid Market, By Region

Chapter 6. Global Bronchoscopes Market, By Usage

  • 6.1 Global Reusable Market, By Region
  • 6.2 Global Disposable Market, By Region

Chapter 7. Global Bronchoscopes Market, By End-use

  • 7.1 Global Hospitals Market, By Region
  • 7.2 Global Outpatient Facilities Market, By Region

Chapter 8. Global Bronchoscopes Market, By Region

  • 8.1 North America Bronchoscopes Market
    • 8.1.1 North America Bronchoscopes Market, By Type
      • 8.1.1.1 North America Flexible Market, By Country
      • 8.1.1.2 North America Bronchoscopes Market, By Flexible Type
        • 8.1.1.2.1 North America Video Market, By Country
        • 8.1.1.2.2 North America Fiberoptic Market, By Country
        • 8.1.1.2.3 North America Hybrid Market, By Country
      • 8.1.1.3 North America Rigid Market, By Country
    • 8.1.2 North America Bronchoscopes Market, By Usage
      • 8.1.2.1 North America Reusable Market, By Country
      • 8.1.2.2 North America Disposable Market, By Country
    • 8.1.3 North America Bronchoscopes Market, By End-use
      • 8.1.3.1 North America Hospitals Market, By Country
      • 8.1.3.2 North America Outpatient Facilities Market, By Country
    • 8.1.4 North America Bronchoscopes Market, By Country
      • 8.1.4.1 US Bronchoscopes Market
        • 8.1.4.1.1 US Bronchoscopes Market, By Type
        • 8.1.4.1.2 US Bronchoscopes Market, By Usage
        • 8.1.4.1.3 US Bronchoscopes Market, By End-use
      • 8.1.4.2 Canada Bronchoscopes Market
        • 8.1.4.2.1 Canada Bronchoscopes Market, By Type
        • 8.1.4.2.2 Canada Bronchoscopes Market, By Usage
        • 8.1.4.2.3 Canada Bronchoscopes Market, By End-use
      • 8.1.4.3 Mexico Bronchoscopes Market
        • 8.1.4.3.1 Mexico Bronchoscopes Market, By Type
        • 8.1.4.3.2 Mexico Bronchoscopes Market, By Usage
        • 8.1.4.3.3 Mexico Bronchoscopes Market, By End-use
      • 8.1.4.4 Rest of North America Bronchoscopes Market
        • 8.1.4.4.1 Rest of North America Bronchoscopes Market, By Type
        • 8.1.4.4.2 Rest of North America Bronchoscopes Market, By Usage
        • 8.1.4.4.3 Rest of North America Bronchoscopes Market, By End-use
  • 8.2 Europe Bronchoscopes Market
    • 8.2.1 Europe Bronchoscopes Market, By Type
      • 8.2.1.1 Europe Flexible Market, By Country
      • 8.2.1.2 Europe Bronchoscopes Market, By Flexible Type
        • 8.2.1.2.1 Europe Video Market, By Country
        • 8.2.1.2.2 Europe Fiberoptic Market, By Country
        • 8.2.1.2.3 Europe Hybrid Market, By Country
      • 8.2.1.3 Europe Rigid Market, By Country
    • 8.2.2 Europe Bronchoscopes Market, By Usage
      • 8.2.2.1 Europe Reusable Market, By Country
      • 8.2.2.2 Europe Disposable Market, By Country
    • 8.2.3 Europe Bronchoscopes Market, By End-use
      • 8.2.3.1 Europe Hospitals Market, By Country
      • 8.2.3.2 Europe Outpatient Facilities Market, By Country
    • 8.2.4 Europe Bronchoscopes Market, By Country
      • 8.2.4.1 Germany Bronchoscopes Market
        • 8.2.4.1.1 Germany Bronchoscopes Market, By Type
        • 8.2.4.1.2 Germany Bronchoscopes Market, By Usage
        • 8.2.4.1.3 Germany Bronchoscopes Market, By End-use
      • 8.2.4.2 UK Bronchoscopes Market
        • 8.2.4.2.1 UK Bronchoscopes Market, By Type
        • 8.2.4.2.2 UK Bronchoscopes Market, By Usage
        • 8.2.4.2.3 UK Bronchoscopes Market, By End-use
      • 8.2.4.3 France Bronchoscopes Market
        • 8.2.4.3.1 France Bronchoscopes Market, By Type
        • 8.2.4.3.2 France Bronchoscopes Market, By Usage
        • 8.2.4.3.3 France Bronchoscopes Market, By End-use
      • 8.2.4.4 Russia Bronchoscopes Market
        • 8.2.4.4.1 Russia Bronchoscopes Market, By Type
        • 8.2.4.4.2 Russia Bronchoscopes Market, By Usage
        • 8.2.4.4.3 Russia Bronchoscopes Market, By End-use
      • 8.2.4.5 Spain Bronchoscopes Market
        • 8.2.4.5.1 Spain Bronchoscopes Market, By Type
        • 8.2.4.5.2 Spain Bronchoscopes Market, By Usage
        • 8.2.4.5.3 Spain Bronchoscopes Market, By End-use
      • 8.2.4.6 Italy Bronchoscopes Market
        • 8.2.4.6.1 Italy Bronchoscopes Market, By Type
        • 8.2.4.6.2 Italy Bronchoscopes Market, By Usage
        • 8.2.4.6.3 Italy Bronchoscopes Market, By End-use
      • 8.2.4.7 Rest of Europe Bronchoscopes Market
        • 8.2.4.7.1 Rest of Europe Bronchoscopes Market, By Type
        • 8.2.4.7.2 Rest of Europe Bronchoscopes Market, By Usage
        • 8.2.4.7.3 Rest of Europe Bronchoscopes Market, By End-use
  • 8.3 Asia Pacific Bronchoscopes Market
    • 8.3.1 Asia Pacific Bronchoscopes Market, By Type
      • 8.3.1.1 Asia Pacific Flexible Market, By Country
      • 8.3.1.2 Asia Pacific Bronchoscopes Market, By Flexible Type
        • 8.3.1.2.1 Asia Pacific Video Market, By Country
        • 8.3.1.2.2 Asia Pacific Fiberoptic Market, By Country
        • 8.3.1.2.3 Asia Pacific Hybrid Market, By Country
      • 8.3.1.3 Asia Pacific Rigid Market, By Country
    • 8.3.2 Asia Pacific Bronchoscopes Market, By Usage
      • 8.3.2.1 Asia Pacific Reusable Market, By Country
      • 8.3.2.2 Asia Pacific Disposable Market, By Country
    • 8.3.3 Asia Pacific Bronchoscopes Market, By End-use
      • 8.3.3.1 Asia Pacific Hospitals Market, By Country
      • 8.3.3.2 Asia Pacific Outpatient Facilities Market, By Country
    • 8.3.4 Asia Pacific Bronchoscopes Market, By Country
      • 8.3.4.1 China Bronchoscopes Market
        • 8.3.4.1.1 China Bronchoscopes Market, By Type
        • 8.3.4.1.2 China Bronchoscopes Market, By Usage
        • 8.3.4.1.3 China Bronchoscopes Market, By End-use
      • 8.3.4.2 Japan Bronchoscopes Market
        • 8.3.4.2.1 Japan Bronchoscopes Market, By Type
        • 8.3.4.2.2 Japan Bronchoscopes Market, By Usage
        • 8.3.4.2.3 Japan Bronchoscopes Market, By End-use
      • 8.3.4.3 India Bronchoscopes Market
        • 8.3.4.3.1 India Bronchoscopes Market, By Type
        • 8.3.4.3.2 India Bronchoscopes Market, By Usage
        • 8.3.4.3.3 India Bronchoscopes Market, By End-use
      • 8.3.4.4 South Korea Bronchoscopes Market
        • 8.3.4.4.1 South Korea Bronchoscopes Market, By Type
        • 8.3.4.4.2 South Korea Bronchoscopes Market, By Usage
        • 8.3.4.4.3 South Korea Bronchoscopes Market, By End-use
      • 8.3.4.5 Singapore Bronchoscopes Market
        • 8.3.4.5.1 Singapore Bronchoscopes Market, By Type
        • 8.3.4.5.2 Singapore Bronchoscopes Market, By Usage
        • 8.3.4.5.3 Singapore Bronchoscopes Market, By End-use
      • 8.3.4.6 Malaysia Bronchoscopes Market
        • 8.3.4.6.1 Malaysia Bronchoscopes Market, By Type
        • 8.3.4.6.2 Malaysia Bronchoscopes Market, By Usage
        • 8.3.4.6.3 Malaysia Bronchoscopes Market, By End-use
      • 8.3.4.7 Rest of Asia Pacific Bronchoscopes Market
        • 8.3.4.7.1 Rest of Asia Pacific Bronchoscopes Market, By Type
        • 8.3.4.7.2 Rest of Asia Pacific Bronchoscopes Market, By Usage
        • 8.3.4.7.3 Rest of Asia Pacific Bronchoscopes Market, By End-use
  • 8.4 LAMEA Bronchoscopes Market
    • 8.4.1 LAMEA Bronchoscopes Market, By Type
      • 8.4.1.1 LAMEA Flexible Market, By Country
      • 8.4.1.2 LAMEA Bronchoscopes Market, By Flexible Type
        • 8.4.1.2.1 LAMEA Video Market, By Country
        • 8.4.1.2.2 LAMEA Fiberoptic Market, By Country
        • 8.4.1.2.3 LAMEA Hybrid Market, By Country
      • 8.4.1.3 LAMEA Rigid Market, By Country
    • 8.4.2 LAMEA Bronchoscopes Market, By Usage
      • 8.4.2.1 LAMEA Reusable Market, By Country
      • 8.4.2.2 LAMEA Disposable Market, By Country
    • 8.4.3 LAMEA Bronchoscopes Market, By End-use
      • 8.4.3.1 LAMEA Hospitals Market, By Country
      • 8.4.3.2 LAMEA Outpatient Facilities Market, By Country
    • 8.4.4 LAMEA Bronchoscopes Market, By Country
      • 8.4.4.1 Brazil Bronchoscopes Market
        • 8.4.4.1.1 Brazil Bronchoscopes Market, By Type
        • 8.4.4.1.2 Brazil Bronchoscopes Market, By Usage
        • 8.4.4.1.3 Brazil Bronchoscopes Market, By End-use
      • 8.4.4.2 Argentina Bronchoscopes Market
        • 8.4.4.2.1 Argentina Bronchoscopes Market, By Type
        • 8.4.4.2.2 Argentina Bronchoscopes Market, By Usage
        • 8.4.4.2.3 Argentina Bronchoscopes Market, By End-use
      • 8.4.4.3 UAE Bronchoscopes Market
        • 8.4.4.3.1 UAE Bronchoscopes Market, By Type
        • 8.4.4.3.2 UAE Bronchoscopes Market, By Usage
        • 8.4.4.3.3 UAE Bronchoscopes Market, By End-use
      • 8.4.4.4 Saudi Arabia Bronchoscopes Market
        • 8.4.4.4.1 Saudi Arabia Bronchoscopes Market, By Type
        • 8.4.4.4.2 Saudi Arabia Bronchoscopes Market, By Usage
        • 8.4.4.4.3 Saudi Arabia Bronchoscopes Market, By End-use
      • 8.4.4.5 South Africa Bronchoscopes Market
        • 8.4.4.5.1 South Africa Bronchoscopes Market, By Type
        • 8.4.4.5.2 South Africa Bronchoscopes Market, By Usage
        • 8.4.4.5.3 South Africa Bronchoscopes Market, By End-use
      • 8.4.4.6 Nigeria Bronchoscopes Market
        • 8.4.4.6.1 Nigeria Bronchoscopes Market, By Type
        • 8.4.4.6.2 Nigeria Bronchoscopes Market, By Usage
        • 8.4.4.6.3 Nigeria Bronchoscopes Market, By End-use
      • 8.4.4.7 Rest of LAMEA Bronchoscopes Market
        • 8.4.4.7.1 Rest of LAMEA Bronchoscopes Market, By Type
        • 8.4.4.7.2 Rest of LAMEA Bronchoscopes Market, By Usage
        • 8.4.4.7.3 Rest of LAMEA Bronchoscopes Market, By End-use

Chapter 9. Company Profiles

  • 9.1 Olympus Corporation
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Recent strategies and developments:
      • 9.1.4.1 Product Launches and Product Expansions:
      • 9.1.4.2 Acquisition and Mergers:
    • 9.1.5 SWOT Analysis
  • 9.2 Ambu A/S
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Business Area & Regional Analysis
    • 9.2.4 Recent strategies and developments:
      • 9.2.4.1 Partnerships, Collaborations, and Agreements:
      • 9.2.4.2 Trials and Approvals:
    • 9.2.5 SWOT Analysis
  • 9.3 Karl Storz SE & Co. KG
    • 9.3.1 Company Overview
    • 9.3.2 SWOT Analysis
  • 9.4 Fujifilm Holdings Corporation
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Product Launches and Product Expansions:
    • 9.4.6 SWOT Analysis
  • 9.5 Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Acquisition and Mergers:
      • 9.5.5.2 Trials and Approvals:
    • 9.5.6 SWOT Analysis
  • 9.6 Cook Medical, Inc. (Cook Group)
    • 9.6.1 Company Overview
    • 9.6.2 SWOT Analysis
  • 9.7 Medtronic PLC
    • 9.7.1 Company overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
    • 9.7.6 SWOT Analysis
  • 9.8 Johnson & Johnson
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental & Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Acquisition and Mergers:
    • 9.8.6 SWOT Analysis
  • 9.9 Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)
    • 9.9.1 Company Overview
    • 9.9.2 SWOT Analysis
  • 9.10. Teleflex, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental Analysis
    • 9.10.4 Research & Development Expense
    • 9.10.5 SWOT Analysis

Chapter 10. Winning Imperatives for Bronchoscopes Market

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제